Antiviral therapy for HCV

被引：0
|
作者：
不详
机构：
来源：
LANCET INFECTIOUS DISEASES | 2009年 / 9卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
引用
收藏
页码：86 / 86
页数：1
相关论文
共 50 条
  • [31] Antiviral therapy in compensated and decompensated cirrhotic patients with chronic HCV infection
    Iacobellis, Angelo
    Andriulli, Angelo
    EXPERT OPINION ON PHARMACOTHERAPY, 2009, 10 (12) : 1929 - 1938
  • [32] Normal liver enzymes no reason to withhold antiviral therapy for chronic HCV
    不详
    FORMULARY, 2004, 39 (07) : 343 - 344
  • [33] The impact of antiviral therapy on the course of chronic HCV infection -: A systematic review
    Almasio, PL
    Venezia, G
    Craxì, A
    PANMINERVA MEDICA, 2003, 45 (03) : 175 - 182
  • [34] HCV Antiviral Therapy in Liver Transplant Candidates and Recipients With Renal Insufficiency
    Verna, Elizabeth C.
    Brown, Robert S., Jr.
    TRANSPLANTATION, 2017, 101 (05) : 924 - 932
  • [35] The Impact of Antiviral (HCV) Therapy on Kidney Function in Liver Transplant Recipient
    Nelson, Kirbylee K.
    Caire, Michael T.
    Kumar, Ambuj
    Morano, Jamie
    Kemmer, Nyingi
    GASTROENTEROLOGY, 2016, 150 (04) : S1101 - S1101
  • [36] The Next Era of HCV Antiviral Therapy Finally Begins: Part 1
    David Bobak
    Current Infectious Disease Reports, 2010, 12 (2) : 77 - 78
  • [37] Pre- and Post-Transplant Antiviral Therapy (HBV, HCV)
    Welker, Martin-Walter
    Zeuzem, Stefan
    VISCERAL MEDICINE, 2016, 32 (02) : 105 - 109
  • [38] Duration of antiviral therapy for cholestatic HCV recurrence may need to be indefinite
    Gopal, DV
    Rosen, HR
    LIVER TRANSPLANTATION, 2003, 9 (04) : 348 - 353
  • [39] The Future of HCV Therapy: NS4B as an Antiviral Target
    Dvory-Sobol, Hadas
    Pang, Philip S.
    Glenn, Jeffrey S.
    VIRUSES-BASEL, 2010, 2 (11): : 2481 - 2492
  • [40] Rheumatoid factor after antiviral therapy in patients with HCV chronic hepatitis
    Riccio, A.
    Conca, P.
    Marzocchella, C.
    Tarantino, G.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2008, 26 (05) : 926 - 928
12345